Options
First-Line Lorlatinib Versus Crizotinib in Asian Patients With Advanced ALK-Positive NSCLC: Five-Year Outcomes From the CROWN Study
Journal
Journal of Thoracic Oncology
Journal Volume
20
Journal Issue
7
Start Page
955-968
ISSN
1556-0864
Date Issued
2025-07
Author(s)
Yi-Long Wu
Hye Ryun Kim
Ross A. Soo
Qing Zhou
Hiroaki Akamatsu
Chao-Hua Chiu
Hidetoshi Hayashi
Sang-We Kim
Yasushi Goto
Terufumi Kato
Jianying Zhou
Victor Ho-Fun Lee
Makoto Nishio
Baohui Han
Dong-Wan Kim
Shun Lu
Anna Polli
Jean-François Martini
Francesca Toffalorio
Chew Hooi Wong
Tony Mok
SDGs
Publisher
Elsevier BV
Type
journal-article